Home | Welcome to Contract Pharma   
Last Updated Saturday, May 18 2013
Print

Financial Report: AMRI



Published August 1, 2012
AMRI
 
2Q Revenues: $50.0 million (-7%)

2Q Earnings: $257,000 (loss of $568,000 2Q11) 

YTD Revenues: $103.7 million (-6%)

YTD Earnings: $3.6 million (loss of $2.0 million YTD11)

Comments: Contract revenue for the quarter was $42.4 million, down 3%. Discovery Services revenue was $8.6 million, down 3%; Development/Small Scale revenue was $8.1 million, down 11%; and Large Scale Manufacturing revenue was flat at $25.7 million. Royalties in the quarter were $7.5 million, up 1%.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On